Phase 2 Study - Erdosteine in Patients With CB/COPD

Completed · Phase 2

Conditions studied: Chronic Bronchitis, Chronic Obstructive Pulmonary Disease

In brief

This clinical study is designed to explore dose ranging and identify methods to demonstrate the efficacy of Erdosteine in patients with stable Chronic Bronchitis associated with Chronic Obstructive Pulmonary Disease.

Key facts

Study ID

NCT00338507

Run by

Adams Respiratory Therapeutics

People needed

400

Starts

2006-03-01

Last updated by the study team

2007-12-06

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients with a clinical diagnosis of stable CB associated with COPD will be entered into this study. CB is diagnosed clinically in patients who have a documented smoking history and who have a daily productive cough for at least 3 months per year over at least 2 consecutive years in the absence of other causes of chronic cough. COPD is defined by the presence of airflow obstruction from spirometry

You may not qualify if…

• asthma, bronchiectasis, or cystic fibrosis; active history of lung cancer, respiratory failure, or a need for long-term oxygen therapy;

Where it is running

• Omnicare Clinical Research — King of Prussia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.